Lindamer Laurie A, Wear Emily, Sadler Georgia Robins
Department of Psychiatry, University of California, San Diego, 9500 Gilman Drive #0603, La Jolla, CA 92093-0603, USA.
BMC Psychiatry. 2006 Oct 30;6:49. doi: 10.1186/1471-244X-6-49.
Health care providers and educators who seek to create health promotion programs and individualized comprehensive care plans for women with schizophrenia are hindered by the lack of data to guide their efforts.
This study tested the hypothesis that women with schizophrenia adhere to mammography screening guidelines at the same rate as other same-age women. The study also investigated the validity of the Health Belief (HB) and Stages of Change (SOC) models for breast cancer screening among women with schizophrenia.
Socio-demographic and clinical variables, as well as knowledge, attitudes, and barriers were assessed as a function of stage of change related to breast cancer screening in 46 women with schizophrenia.
Women with schizophrenia were statistically less likely to be adherent to the screening recommendations than those without schizophrenia. Some support was found for the validity of the HB and SOC models for breast cancer screening in women with schizophrenia. Women in the Precontemplation stage had significantly higher negative attitude scores compared to Contemplation and Action/Maintenance stages (59.7, 45.7, and 43.2, respectively), and there was a trend for more barriers in the Precontemplation group (4.6, 2.6, 2.7 respectively).
Given the small sample size, further research on the rates of breast cancer screening in women with schizophrenia is warranted. Nonetheless, these data suggest that providers who care for women with schizophrenia may need to make take additional measures to ensure that this population receives appropriate screening so as to not put them at greater risk for a late-stage diagnosis of breast cancer. Furthermore, these pilot data suggest that HB and SOC theory-based interventions may be valid for increasing mammography rates in women with schizophrenia.
寻求为精神分裂症女性制定健康促进计划和个性化综合护理计划的医疗保健提供者和教育工作者，因缺乏指导其工作的数据而受到阻碍。
本研究检验了以下假设，即精神分裂症女性进行乳房X光检查筛查的依从率与其他同龄女性相同。该研究还调查了健康信念（HB）模型和行为改变阶段（SOC）模型在精神分裂症女性乳腺癌筛查中的有效性。
对46名精神分裂症女性的社会人口统计学和临床变量，以及与乳腺癌筛查相关的行为改变阶段的知识、态度和障碍进行了评估。
与没有精神分裂症的女性相比，精神分裂症女性在统计学上更不太可能遵守筛查建议。在精神分裂症女性乳腺癌筛查中，发现HB和SOC模型的有效性得到了一些支持。与沉思阶段和行动/维持阶段相比，处于未考虑阶段的女性的消极态度得分显著更高（分别为59.7、45.7和43.2），并且在未考虑阶段组中存在更多障碍的趋势（分别为4.6、2.6、2.7）。
鉴于样本量较小，有必要对精神分裂症女性的乳腺癌筛查率进行进一步研究。尽管如此，这些数据表明，照顾精神分裂症女性的提供者可能需要采取额外措施，以确保这一人群接受适当的筛查，以免使她们面临更高的乳腺癌晚期诊断风险。此外，这些初步数据表明，基于HB和SOC理论的干预措施可能对提高精神分裂症女性的乳房X光检查率有效。
